The Economics of Hepatitis B Virus Vaccination: An Analysis of Cost-Effectiveness Results for Switzerland

ISSN： 1173-8790

Source： Disease Management & Health Outcomes, Vol.7, Iss.6, 2000-06, pp. : 331-347

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vaccination against hepatitis B virus in Spain: a cost-effectiveness analysis

By Garuz R. Torrea J.L. Arnal J.M. Forcen T. Trinxet C. Anton F. Antonanzas F.

Vaccine, Vol. 15, Iss. 15, 1997-10 ,pp. : 1652-1660

Elsevier

Access to resources Recommend Favorite

Cost-effectiveness of hepatitis B vaccination of prison inmates

By Pisu M. Meltzer M.I. Lyerla R.

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 312-321

Elsevier

Access to resources Recommend Favorite

Immunization programme against hepatitis B virus infection in Italy: cost-effectiveness

By Da Villa G. Sepe A.

Vaccine, Vol. 17, Iss. 13, 1999-01 ,pp. : 1734-1738

Elsevier

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Entecavir versus Lamivudine in the First-Line Treatment of Australian Patients with Chronic Hepatitis B

By Arnold Elizabeth

Applied Health Economics and Health Policy, Vol. 6, Iss. 4, 2008-01 ,pp. : 231-246

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Vaccination against Rotavirus with RIX4414 in France

By Standaert Baudouin

Applied Health Economics and Health Policy, Vol. 6, Iss. 4, 2008-01 ,pp. : 199-216

Adis International

Access to resources Recommend Favorite